Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Senem Akkoç

Senem Akkoç

Süleyman Demirel University, Turkey

Title: Anticancer activity studies in different cell lines of various organic compounds

Biography

Biography: Senem Akkoç

Abstract

Benzimidazole and its derivatives demonstrate pharmacological activities and they also have a significant role as therapeutic agents. For example: there are few drugs containing benzimidazole nucleus showing following biological activity such as fungicidal, bactericidal, analgesic, anticancer and antiviral properties. The 5,6-dimethyl-1-(α-D-ribofuranosyl) benzimidazole ring system as an integral part of the structure of vitamin B12, which is discovered by Bonnett in 1948, is also including benzimidazole nucleus. Here, four new benzimidazolium salts were synthesized and characterized by 1H NMR, 13C NMR, IR and elemental analysis (Figure 1). Energy values of salts were calculated using the Spartan 10 program. The cytotoxic activities of compounds were determined as testing against the following cell lines: DLD-1, MDA-MB-231, HepG2, Beas-2B, HEK-293T using MTT assay methods for in-vitro cytotoxicity. Cisplatin was used as positive control drug. As a result, all organic compounds exhibited akin to or better results than cisplatin against the tested cell lines, and hence can be considered for further development for cancer therapy. Furthermore, microscopic examination of cells was done using Leica inverted microscopy and Olympus confocal microscope.